|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02225 JINHAI MED-NEW
Nominal 
0.000 (0.000%) | 2024/06 - Interim SGD(K$) | 2023/12 SGD(K$) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (1,910) | 4,241 | 3,339 | 7,384 |
| Net Cash from / (used in) Investing Activities | -- | (6,508) | (1,150) | (2,644) | (6,043) |
| Net Cash from / (used in) Financing Activities | -- | 13,623 | (3,722) | (4,809) | (4,148) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 5,205 | (631) | (4,115) | (2,807) |
| Cash & Cash Equivalents at beginning of period | -- | 15,385 | 16,257 | 20,250 | 21,660 |
| Effect of Foreign Exchange Rate Changes | -- | (394) | (241) | 122 | (251) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 20,196 | 15,385 | 16,257 | 18,603 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | SGD -6,043,000 |
| %Change | -- |
| EPS / (LPS) | SGD -0.001 |
| NBV Per Share ($) | SGD 0.007 |